226 related articles for article (PubMed ID: 10931458)
1. Expression of cyclooxygenase-2 in prostate carcinoma.
Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-1 and -2 in human breast cancer.
Yoshimura N; Sano H; Okamoto M; Akioka K; Ushigome H; Kadotani Y; Yoshimura R; Nobori S; Higuchi A; Ohmori Y; Nakamura K
Surg Today; 2003; 33(11):805-11. PubMed ID: 14605950
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
5. Study of cyclooxygenase-2 in renal cell carcinoma.
Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
König JE; Senge T; Allhoff EP; König W
Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.
Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG
Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153
[TBL] [Abstract][Full Text] [Related]
8. Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.
Segawa Y; Yoshimura R; Hase T; Nakatani T; Wada S; Kawahito Y; Kishimoto T; Sano H
Prostate; 2002 May; 51(2):108-16. PubMed ID: 11948965
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
[TBL] [Abstract][Full Text] [Related]
10. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in patients with bladder carcinoma.
Yoshimura R; Sano H; Mitsuhashi M; Kohno M; Chargui J; Wada S
J Urol; 2001 May; 165(5):1468-72. PubMed ID: 11342898
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
Sano H; Kawahito Y; Wilder RL; Hashiramoto A; Mukai S; Asai K; Kimura S; Kato H; Kondo M; Hla T
Cancer Res; 1995 Sep; 55(17):3785-9. PubMed ID: 7641194
[TBL] [Abstract][Full Text] [Related]
13. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 promotes prostate cancer progression.
Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
[TBL] [Abstract][Full Text] [Related]
15. The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer.
Mukherjee R; Edwards J; Underwood MA; Bartlett JM
BJU Int; 2005 Jul; 96(1):62-6. PubMed ID: 15963122
[TBL] [Abstract][Full Text] [Related]
16. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
Wang KJ; Li H; Wei Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
[TBL] [Abstract][Full Text] [Related]
17. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.
Banerjee AG; Liu J; Yuan Y; Gopalakrishnan VK; Johansson SL; Dinda AK; Gupta NP; Trevino L; Vishwanatha JK
Mol Cancer; 2003 Oct; 2():34. PubMed ID: 14613585
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
[TBL] [Abstract][Full Text] [Related]
19. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
Zang T; Sun F; Li Y
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
